Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Midecamycin, an acetoxy-substituted macrolide Antibiotic, has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.
Description | Midecamycin, an acetoxy-substituted macrolide antibiotic, has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis. |
In vitro | Midecamycin inhibits the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 μg/mL [1]. Midecamycin is a novel 16-membered macrolide antibiotic, which is produced by Streptomyces mycarofaciens [2]. |
Synonyms | Turimycin P3, Medecamycin A1, Espinomycin A, Platenomycin B1, Rubimycin, Antibiotic SF-837 |
Molecular Weight | 813.97 |
Formula | C41H67NO15 |
CAS No. | 35457-80-8 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 50 mg/mL
Ethanol: 50 mg/mL
H2O: Insoluble
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Midecamycin 35457-80-8 Microbiology/Virology Antibacterial Antibiotic SF837 Antibiotic SF 837 Bacterial inhibit Antibiotic SF837 Turimycin P3 Medecamycin A1 Inhibitor SF-837 Espinomycin A Platenomycin B1 SF 837 Rubimycin Antibiotic SF-837 inhibitor